Phathom Pharmaceuticals

Home » Phathom Pharmaceuticals

IPO

Phathom Pharmaceuticals

Biopharmaceutical

We are a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases.

Symbol

PHAT

Price Range
$18.00 - $20.00

Final Shares
7,900,000

Anticipated Date
October 25, 2019

Underwriters
GOLDMAN SACHS & CO. LLC ,NEEDHAM & COMPANY, LLC

To view the prospectus for Phathom Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253